| Year |
Citation |
Score |
| 2022 |
Casavant EP, Liang J, Sankhe S, Mathews WR, Anania VG. Using SILAC to Develop Quantitative Data-Independent Acquisition (DIA) Proteomic Methods. Methods in Molecular Biology (Clifton, N.J.). 2603: 245-257. PMID 36370285 DOI: 10.1007/978-1-0716-2863-8_20 |
0.34 |
|
| 2018 |
Anania VG, Yu K, Pingitore F, Li Q, Rose CM, Liu P, Sandoval W, Herman AE, Lill JR, Mathews WR. Discovery and qualification of candidate urinary biomarkers of disease activity in lupus nephritis. Journal of Proteome Research. PMID 30525646 DOI: 10.1021/Acs.Jproteome.8B00874 |
0.324 |
|
| 2017 |
Anania V, Li Q, Cascino M, Dragone L, Liu P, Sandoval W, Katsumoto T, Morimoto A, Herman A, Mathews W. 38 Discovery and evaluation of a multiplexed mass spectrometry panel for measuring candidate peptide biomarkers in urine from patients with lupus nephritis Lupus Science & Medicine. 4. DOI: 10.1136/Lupus-2017-000215.38 |
0.431 |
|
| 2016 |
Fasci D, Anania V, Lill J, Salvesen G. Response to Comment on "SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML". Science Signaling. 9: tc2. PMID 27507652 DOI: 10.1126/Scisignal.Aad9777 |
0.318 |
|
| 2016 |
Anania VG, Yu K, Gnad F, Pferdehirt RR, Li H, Ma T, Jeon D, Fortelny N, Forrest W, Ashkenazi A, Overall CM, Lill JR. Uncovering a dual regulatory role for caspases during endoplasmic reticulum stress-induced cell death. Molecular & Cellular Proteomics : McP. PMID 27125827 DOI: 10.1074/Mcp.M115.055376 |
0.334 |
|
| 2016 |
Anania V, Cascino M, Dragone L, Looney C, Rae J, Liu P, Sandoval W, Katsumoto T, Neighbors M, Morimoto A, Herman A, Mathews W. AB0156 Quantitative Proteomic Approaches for Identifying Urinary Biomarkers in Lupus Nephritis Annals of the Rheumatic Diseases. 75: 950.1-950. DOI: 10.1136/Annrheumdis-2016-Eular.4468 |
0.361 |
|
| 2015 |
Fasci D, Anania VG, Lill JR, Salvesen GS. SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML. Science Signaling. 8: ra56. PMID 26060329 DOI: 10.1126/Scisignal.Aaa3929 |
0.358 |
|
| 2015 |
Anania VG, Lill JR. Proteomic tools for the characterization of cell death mechanisms in drug discovery. Proteomics. Clinical Applications. 9: 671-83. PMID 25708855 DOI: 10.1002/Prca.201400151 |
0.343 |
|
| 2014 |
Pham VC, Anania VG, Phung QT, Lill JR. Complementary methods for the identification of substrates of proteolysis. Methods in Enzymology. 544: 359-80. PMID 24974297 DOI: 10.1016/B978-0-12-417158-9.00014-5 |
0.404 |
|
| 2014 |
Wang J, Anania VG, Knott J, Rush J, Lill JR, Bourne PE, Bandeira N. Combinatorial approach for large-scale identification of linked peptides from tandem mass spectrometry spectra. Molecular & Cellular Proteomics : McP. 13: 1128-36. PMID 24493012 DOI: 10.1074/Mcp.M113.035758 |
0.408 |
|
| 2014 |
Wang J, Anania VG, Knott J, Rush J, Lill JR, Bourne PE, Bandeira N. A turn-key approach for large-scale identification of complex posttranslational modifications. Journal of Proteome Research. 13: 1190-9. PMID 24437954 DOI: 10.1021/Pr400368U |
0.389 |
|
| 2014 |
Anania VG, Pham VC, Huang X, Masselot A, Lill JR, Kirkpatrick DS. Peptide level immunoaffinity enrichment enhances ubiquitination site identification on individual proteins. Molecular & Cellular Proteomics : McP. 13: 145-56. PMID 24142993 DOI: 10.1074/Mcp.M113.031062 |
0.469 |
|
| 2013 |
Anania VG, Bustos DJ, Lill JR, Kirkpatrick DS, Coscoy L. A Novel Peptide-Based SILAC Method to Identify the Posttranslational Modifications Provides Evidence for Unconventional Ubiquitination in the ER-Associated Degradation Pathway. International Journal of Proteomics. 2013: 857918. PMID 23431445 DOI: 10.1155/2013/857918 |
0.532 |
|
| 2012 |
Pham VC, Pitti R, Anania VG, Bakalarski CE, Bustos D, Jhunjhunwala S, Phung QT, Yu K, Forrest WF, Kirkpatrick DS, Ashkenazi A, Lill JR. Complementary proteomic tools for the dissection of apoptotic proteolysis events. Journal of Proteome Research. 11: 2947-54. PMID 22432722 DOI: 10.1021/Pr300035K |
0.411 |
|
| 2011 |
Anania VG, Coscoy L. Palmitoylation of MIR2 is required for its function. Journal of Virology. 85: 2288-95. PMID 21159884 DOI: 10.1128/Jvi.01961-10 |
0.478 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
D'Osualdo A, Anania VG, Yu K, Lill JR, Kaufman RJ, Matsuzawa S, Reed JC. Transcription Factor ATF4 Induces NLRP1 Inflammasome Expression during Endoplasmic Reticulum Stress. Plos One. 10: e0130635. PMID 26086088 DOI: 10.1371/Journal.Pone.0130635 |
0.283 |
|
| 2021 |
Olsson N, Heberling ML, Zhang L, Jhunjhunwala S, Phung QT, Lin S, Anania VG, Lill JR, Elias JE. An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens. Frontiers in Immunology. 12: 662443. PMID 33936100 DOI: 10.3389/fimmu.2021.662443 |
0.282 |
|
| 2020 |
Anania VG, Randolph AG, Yang X, Nguyen A, Newhams MM, Mathews WR, Rosenberger CM, McBride JM. Early Amplified Respiratory Bioactive Lipid Response Is Associated With Worse Outcomes in Pediatric Influenza-Related Respiratory Failure. Open Forum Infectious Diseases. 7: ofaa122. PMID 32420403 DOI: 10.1093/Ofid/Ofaa122 |
0.231 |
|
| 2024 |
Perez-Paramo YX, Dufield D, Veeramachaneni R, Parkhurst E, Harp C, Ramesh A, Winger RC, Cross AH, Gelfand JM, Bar-Or A, Mathews WR, Anania VG. Development of an LC-MS/MS method to measure sphingolipids in CSF from patients with multiple sclerosis. Molecular Pharmacology. PMID 38182433 DOI: 10.1124/molpharm.123.000779 |
0.131 |
|
| 2021 |
Chakrabarti A, Nguyen A, Newhams MM, Ohlson MB, Yang X, Ulufatu S, Liu S, Park S, Xu M, Jiang J, Halpern WG, Anania VG, McBride JM, Rosenberger CM, Randolph AG, et al. Surfactant Protein D is a Biomarker of Influenza-Related Pediatric Lung Injury. Pediatric Pulmonology. PMID 34842360 DOI: 10.1002/ppul.25776 |
0.121 |
|
| 2024 |
Harder BJ, Lekkerkerker AN, Casavant EP, Hackney JA, Nguyen A, McBride JM, Mathews WR, Anania VG. Comprehensive profiling of the human fecal proteome from IBD patients with DIA-MS enables evaluation of disease-relevant proteins. Proteomics. Clinical Applications. e2300075. PMID 38552248 DOI: 10.1002/prca.202300075 |
0.12 |
|
| 2024 |
Cross AH, Gelfand JM, Thebault S, Bennett JL, von Büdingen HC, Cameron B, Carruthers R, Edwards K, Fallis R, Gerstein R, Giacomini PS, Greenberg B, Hafler DA, Ionete C, Kaunzner UW, ... ... Anania VG, et al. Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis. Jama Neurology. PMID 38466277 DOI: 10.1001/jamaneurol.2024.0017 |
0.094 |
|
| 2023 |
Bennett JL, Fujihara K, Kim HJ, Marignier R, O'Connor KC, Sergott RC, Traboulsee A, Wiendl H, Wuerfel J, Zamvil SS, Anania VG, Buffels R, Künzel T, Lekkerkerker AN, Lennon-Chrimes S, et al. SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab. Frontiers in Neurology. 14: 1114667. PMID 36873431 DOI: 10.3389/fneur.2023.1114667 |
0.086 |
|
| 2023 |
Monteiro C, Toth B, Brunstein F, Bobbala A, Datta S, Ceniceros R, Bohorquez SS, Anania V, Wildsmith K, Schauer S, Lee J, Dolton M, Ramakrishnan V, Abramzon D, Teng E. A Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants with Mild-to-Moderate Alzheimer's Disease (Lauriet). Neurology. PMID 37643887 DOI: 10.1212/WNL.0000000000207663 |
0.045 |
|
| Hide low-probability matches. |